Vaccine Therapy in Treating Patients With Stage IV Hormone Receptor Positive Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01729884
Recruitment Status : Terminated (Study ended early due to slow enrollment)
First Posted : November 20, 2012
Last Update Posted : April 11, 2017
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Mary (Nora) Disis, University of Washington

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : June 2013
  Study Completion Date : No date given
  Certification/Extension First Submitted : April 3, 2017